[1]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96-97.
 MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):96-97.
点击复制

血塞通联合西药治疗糖尿病肾病80例
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年08期
页码:
96-97
栏目:
报道·衷中参西
出版日期:
2013-08-15

文章信息/Info

Title:
XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy
文章编号:
1004-6852(2013)08-0096-02
作者:
马天寿
临洮县人民医院,甘肃 临洮 730500
Author(s):
MA Tianshou
Lintao County People′s Hospital, Lintao 730500, China
关键词:
糖尿病肾病血塞通氯沙坦
Keywords:
diabetic nephropathy XueSaiTong losartan
分类号:
R276.746
文献标志码:
B
摘要:
目的:观察血塞通联合西药治疗糖尿病肾病的临床疗效。方法:将160例糖尿病患者随机分为观察组、对照组各80例。2组均予氯沙坦50 mg/d,口服。观察组在此基础上给予血塞通注射液0.45 g加入250 mL生理盐水,静脉滴注,1次/d。2组均以15天为1个疗程,连续治疗2个疗程后观察疗效,疗程间休息5天。结果:治愈率观察组为67.50%,对照组为55.00%,2组相比差异有统计学意义(P<0.05)。总有效率观察组为92.50%,对照组为82.50%,2组相比差异有统计学意义(P<0.05)。2组患者治疗后疲倦乏力、腹胀纳呆、腰膝酸软、大便溏、浮肿等症状积分比较,差异有统计学意义(P<0.05)。结论:血塞通联合西药治疗糖尿病肾病临床疗效优于单纯西药治疗。
Abstract:
Objective: To explore clinical effects of XueSaiTong injection and western medicine in the treatment for diabetic nephropathy. Method: All 160 patients were randomized into the observation group and the control group. Both groups took losartan, 50mg/d. The observation group received intravenous dripping of XueSaiTong injection, 0.45g, and physiological saline, 250mL, once per day. One course of treatment was 15 days, both groups were treated for two courses of treatment to observe clinical effects, the interval was five days. Result: Cure rates of the observation group and the control group were 67.50% and 55.00%, the difference had statistical meaning(P<0.05). Total effective rates of both groups were 92.50% and 82.50%, the difference had statistical meaning(P<0.05). the differences had statistical meanings of the comparison between both groups in symptom scales of lassitude and fatigue, abdominal distention and anorexia, soreness and weakness of the waist and the knees, loose stool and edema (P<0.05). Conclusion: XueSaiTong injection and western medicine could gain notable effects in the treatment for diabetic nephropathy.

相似文献/References:

[1]朱苗蕊,指导:金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
 ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):74.
[2]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
 LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):68.
[3]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
 LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):68.
[4]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
 WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):62.
[5]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
 REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(08):1.
[6]杨华,曾娟花.血清TNF与2型糖尿病肾病及其中医证型关系的临床研究[J].西部中医药,2014,27(01):11.
 YANG Hua,ZENG Juanhua.Clinical Study on the Relationship between Serum TNF and Type 2 Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(08):11.
[7]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
 REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(08):77.
[8]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
 DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(08):96.
[9]孙慧,李彩萍.雷公藤多苷联合二甲双胍治疗糖尿病肾病临床观察[J].西部中医药,2014,27(07):82.
 SUN Hui,LI Caiping.Clinical Observation on Tripterygium Glycosides and Metformin in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(08):82.
[10]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.

备注/Memo

备注/Memo:
收稿日期:2013-01-10 作者简介:马天寿(1968—),男,副主任医师。研究方向:肾脏疾病的中医诊治。
更新日期/Last Update: 2013-08-15